SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Resonance Specialties touches roof after USFDA inspects its manufacturing site in Bhopal

17 Oct 2016 Evaluate

Resonance Specialties is locked at upper circuit at Rs. 40.50, up by 1.90 points or 4.92% from its previous closing of Rs. 38.60 on the BSE.

The scrip opened at Rs. 40.50 and has touched a high and low of Rs. 40.50 and Rs. 40.00 respectively. So far 34,000 shares were traded on the counter.

The BSE group 'XD' stock of face value Rs. 10 has touched a 52 week high of Rs. 43.70 on 13-Oct-2016 and a 52 week low of Rs. 17.15 on 15-Feb-2016.

Last one week high and low of the scrip stood at Rs. 43.70 and Rs. 38.60 respectively. The current market cap of the company is Rs. 46.75 crore.

The promoters holding in the company stood at 64.72%, while Institutions and Non-Institutions held 0.07% and 35.21% respectively.

Resonance Specialties’ one of its manufacturing site - Vista Organics, Mandideep, (Bhopal) has been recently inspected by the USFDA (US Food and Drug Administration). No 483 observations have been issued and EIR (Establishment Inspection Report) is awaited by the company.

Resonance Specialties is a pioneer in Pyridine chemistry and one of the few manufacturers of the product in the world. The company is also one of the largest manufacturers of Lutidines in the world.


Resonance Specialtie Share Price

99.96 0.96 (0.97%)
20-Apr-2026 10:59 View Price Chart
Peers
Company Name CMP
BASF India 3694.40
Tata Chemicals 709.60
SRF 2481.60
Pidilite Inds. 1397.65
Deepak Nitrite 1528.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×